Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Other Operating Expenses (2019 - 2025)

Silo Pharma's Other Operating Expenses history spans 7 years, with the latest figure at $605189.0 for Q3 2025.

  • For Q3 2025, Other Operating Expenses rose 18.88% year-over-year to $605189.0; the TTM value through Sep 2025 reached $2.4 million, down 0.73%, while the annual FY2024 figure was $2.4 million, 10.53% down from the prior year.
  • Other Operating Expenses for Q3 2025 was $605189.0 at Silo Pharma, up from $547870.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $2.1 million in Q4 2022 and bottomed at $265202.0 in Q2 2021.
  • The 5-year median for Other Operating Expenses is $552172.0 (2023), against an average of $674873.3.
  • The largest YoY upside for Other Operating Expenses was 642.31% in 2021 against a maximum downside of 72.54% in 2021.
  • A 5-year view of Other Operating Expenses shows it stood at $1.1 million in 2021, then soared by 89.79% to $2.1 million in 2022, then plummeted by 60.13% to $843325.0 in 2023, then fell by 10.57% to $754199.0 in 2024, then decreased by 19.76% to $605189.0 in 2025.
  • Per Business Quant, the three most recent readings for SILO's Other Operating Expenses are $605189.0 (Q3 2025), $547870.0 (Q2 2025), and $516725.0 (Q1 2025).